MADHAVBAUG — Vaidya Sane Ayurved Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹1.55bn
- IN₹1.38bn
- IN₹990.25m
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 625 | 752 | 523 | 747 | 990 |
Cost of Revenue | |||||
Gross Profit | 449 | 527 | 346 | 516 | 700 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 611 | 748 | 515 | 699 | 928 |
Operating Profit | 13.8 | 4.21 | 7.54 | 48 | 62.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.82 | -4.47 | 4.55 | 47.5 | 69.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.96 | -5.57 | 3.92 | 34.7 | 51.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.96 | -5.57 | 3.92 | 34.7 | 51.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.96 | -5.57 | 3.92 | 34.7 | 51.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 110 | -0.53 | 0.403 | 3.3 | 4.94 |
Dividends per Share |